Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthijs Kox

Showing results (51-60 of 200) with videos related to

Pageof 20
Sort By:
Shock (Augusta, Ga.)|June 26, 2021
Wearable Patch Heart Rate Variability Is an Early Marker of Systemic Inflammation During Experimental Human EndotoxemiaMats Koeneman, Rebecca Koch, Harry van Goor, et al.
Innate Immunity|February 21, 2019
Comparison of different lots of endotoxin and evaluation of in vivo potency over time in the experimental human endotoxemia modelDorien Kiers, Guus P Leijte, Jelle Gerretsen, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2013
Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?Jenneke Leentjens, Matthijs Kox, Johannes G van der Hoeven, et al.
Journal of Leukocyte Biology|January 11, 2020
Differentiation and activation of eosinophils in the human bone marrow during experimental human endotoxemiaMarwan Hassani, Guus Leijte, Niklas Bruse, et al.
Journal of Innate Immunity|August 8, 2022
Ex vivo and in vitro Monocyte Responses Do Not Reflect in vivo Immune Responses and ToleranceAron Jansen, Niklas Bruse, Nicole Waalders, et al.
Critical Care Medicine|August 19, 2009
Nitric oxide inhalation and glucocorticoids as combined treatment in human experimental endotoxemia: It takes not always two to tangoJan C Pompe, Matthijs Kox, Cornelia W Hoedemaekers, et al.
Critical Care Medicine|September 22, 2007
A possible role for the cholinergic anti-inflammatory pathway in increased mortality observed in critically ill patients receiving nicotine replacement therapyMatthijs Kox, Astrid W Hoedemaekers, Peter Pickkers, et al.
Journal of Critical Care|February 28, 2015
Soluble urokinase-type plasminogen activator levels are related to plasma cytokine levels but have low predictive value for mortality in trauma patientsKim Timmermans, Michiel Vaneker, Gert Jan Scheffer, et al.
Critical Care (London, England)|March 22, 2023
CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivoAron Jansen, Nicole J B Waalders, Dirk P T van Lier, et al.
ERJ Open Research|March 19, 2021
Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patientsDirk van Lier, Matthijs Kox, Karine Santos, et al.
Pageof 20

Showing results (51-60 of 200) with videos related to

Sort By:
Pageof 20
Shock (Augusta, Ga.)|June 26, 2021
Wearable Patch Heart Rate Variability Is an Early Marker of Systemic Inflammation During Experimental Human EndotoxemiaMats Koeneman, Rebecca Koch, Harry van Goor, et al.
Innate Immunity|February 21, 2019
Comparison of different lots of endotoxin and evaluation of in vivo potency over time in the experimental human endotoxemia modelDorien Kiers, Guus P Leijte, Jelle Gerretsen, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2013
Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?Jenneke Leentjens, Matthijs Kox, Johannes G van der Hoeven, et al.
Journal of Leukocyte Biology|January 11, 2020
Differentiation and activation of eosinophils in the human bone marrow during experimental human endotoxemiaMarwan Hassani, Guus Leijte, Niklas Bruse, et al.
Journal of Innate Immunity|August 8, 2022
Ex vivo and in vitro Monocyte Responses Do Not Reflect in vivo Immune Responses and ToleranceAron Jansen, Niklas Bruse, Nicole Waalders, et al.
Critical Care Medicine|August 19, 2009
Nitric oxide inhalation and glucocorticoids as combined treatment in human experimental endotoxemia: It takes not always two to tangoJan C Pompe, Matthijs Kox, Cornelia W Hoedemaekers, et al.
Critical Care Medicine|September 22, 2007
A possible role for the cholinergic anti-inflammatory pathway in increased mortality observed in critically ill patients receiving nicotine replacement therapyMatthijs Kox, Astrid W Hoedemaekers, Peter Pickkers, et al.
Journal of Critical Care|February 28, 2015
Soluble urokinase-type plasminogen activator levels are related to plasma cytokine levels but have low predictive value for mortality in trauma patientsKim Timmermans, Michiel Vaneker, Gert Jan Scheffer, et al.
Critical Care (London, England)|March 22, 2023
CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivoAron Jansen, Nicole J B Waalders, Dirk P T van Lier, et al.
ERJ Open Research|March 19, 2021
Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patientsDirk van Lier, Matthijs Kox, Karine Santos, et al.
Pageof 20